FI925875A7 - Menetelmä uusien proteolyyttisten entsyymien inhibiittoreina käyttökelpoisten 2-sakkarinyylimetyyli- ja 4,5,6,7-tetrahydro-2-sakkarinyylimetyylifosfaattien, -fosfonaattien ja -fosfinaattien valmistamiseksi - Google Patents

Menetelmä uusien proteolyyttisten entsyymien inhibiittoreina käyttökelpoisten 2-sakkarinyylimetyyli- ja 4,5,6,7-tetrahydro-2-sakkarinyylimetyylifosfaattien, -fosfonaattien ja -fosfinaattien valmistamiseksi Download PDF

Info

Publication number
FI925875A7
FI925875A7 FI925875A FI925875A FI925875A7 FI 925875 A7 FI925875 A7 FI 925875A7 FI 925875 A FI925875 A FI 925875A FI 925875 A FI925875 A FI 925875A FI 925875 A7 FI925875 A7 FI 925875A7
Authority
FI
Finland
Prior art keywords
saccharinylmethyl
phosphonates
tetrahydro
inhibitors
preparation
Prior art date
Application number
FI925875A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI925875L (fi
FI925875A0 (fi
Inventor
Dennis John Hlasta
Ranjit Chimanlal Desai
Chakrapani Subramanyam
John Joseph Court
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of FI925875A0 publication Critical patent/FI925875A0/fi
Publication of FI925875A7 publication Critical patent/FI925875A7/fi
Publication of FI925875L publication Critical patent/FI925875L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539Five-membered rings
    • C07F9/6541Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus
    • C07F9/65742Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus
    • C07F9/65744Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI925875A 1991-12-27 1992-12-23 Foerfarande foer framstaellning av nya som inhibitorer av proteolytiska enzymer anvaendbara 2-sackarinylmetyl- och 4,5,6,7-tetrahydro-2-sackarinylmetylfosfater, -fosfonater och -fosfinater FI925875L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/814,741 US5187173A (en) 1991-12-27 1991-12-27 2-saccharinylmethyl and 4,5,6,7-tetrahydro-2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof

Publications (3)

Publication Number Publication Date
FI925875A0 FI925875A0 (fi) 1992-12-23
FI925875A7 true FI925875A7 (fi) 1993-06-28
FI925875L FI925875L (fi) 1993-06-28

Family

ID=25215883

Family Applications (1)

Application Number Title Priority Date Filing Date
FI925875A FI925875L (fi) 1991-12-27 1992-12-23 Foerfarande foer framstaellning av nya som inhibitorer av proteolytiska enzymer anvaendbara 2-sackarinylmetyl- och 4,5,6,7-tetrahydro-2-sackarinylmetylfosfater, -fosfonater och -fosfinater

Country Status (22)

Country Link
US (1) US5187173A (enExample)
EP (1) EP0549073B1 (enExample)
JP (1) JPH05271262A (enExample)
AT (1) ATE150755T1 (enExample)
AU (1) AU648938B2 (enExample)
CA (1) CA2085427A1 (enExample)
CZ (1) CZ371692A3 (enExample)
DE (1) DE69218568T2 (enExample)
DK (1) DK0549073T3 (enExample)
ES (1) ES2100274T3 (enExample)
FI (1) FI925875L (enExample)
GR (1) GR3023632T3 (enExample)
HU (1) HUT63630A (enExample)
IL (3) IL104229A (enExample)
MX (1) MX9207542A (enExample)
MY (1) MY106897A (enExample)
NO (1) NO303639B1 (enExample)
NZ (1) NZ245585A (enExample)
RU (1) RU2091377C1 (enExample)
SG (1) SG48310A1 (enExample)
SK (1) SK371692A3 (enExample)
TW (1) TW225538B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5236917A (en) * 1989-05-04 1993-08-17 Sterling Winthrop Inc. Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5296496A (en) * 1991-12-27 1994-03-22 Sterling Winthrop Inc. 2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
AU653279B2 (en) * 1991-12-30 1994-09-22 Sanofi Novel 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5541168A (en) * 1994-12-02 1996-07-30 Sterling Winthrop Inc. Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
IL163748A0 (en) * 2002-03-05 2005-12-18 Merck Frosst Canada Inc Cathepsin cysteine protease inhibitors
CA2479256A1 (en) * 2002-03-20 2003-10-02 Bristol-Myers Squibb Company Phosphate prodrugs of fluorooxindoles
DK1865940T3 (da) * 2005-03-21 2013-03-04 Virobay Inc Alfaketoamidforbindelser som cysteinproteasehæmmere

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3002884A (en) * 1959-04-15 1961-10-03 Rohm & Haas Horticultural process with n-halomethyl-1,2-benzisothiazolin - 3 - one-1,1-dioxides for controlling fungus diseases
US3314960A (en) * 1964-08-25 1967-04-18 American Home Prod Benzisothiazol glutarimides
FR1451417A (fr) * 1965-07-15 1966-01-07 Roussel Uclaf Nouveaux esters d'acides cycliques et leur procédé de préparation
US4195023A (en) * 1975-08-20 1980-03-25 Merck & Co., Inc. 2-(2-Furoyl)1,2-benzisothiazole-3-one, 2-(2-furoyl) saccharin, and 2-(2-thenoyl) saccharin
US4276298A (en) * 1978-03-24 1981-06-30 Merck & Co., Inc. 2-Aryl-1,2-benzisothiazolinone-1,1-dioxides and their use as selective protease inhibitors
US4263393A (en) * 1979-09-06 1981-04-21 Eastman Kodak Company Novel electron donor precursors and photographic element containing them
US4350752A (en) * 1980-12-29 1982-09-21 Eastman Kodak Company Photographic elements and film units containing imidomethyl blocked photographic reagents
US4363865A (en) * 1981-03-04 1982-12-14 Eastman Kodak Company Imido methyl blocked photographic dyes and dye releasing compounds
US4410618A (en) * 1982-06-11 1983-10-18 Eastman Kodak Company Blocked photographic reagents
US4547371A (en) * 1983-04-18 1985-10-15 Merck & Co., Inc. Substituted cephalosporin sulfones as anti-inflammatory and anti-degenerative agents
US4623645A (en) * 1983-04-18 1986-11-18 Merck & Co., Inc. Substituted cephalosporin sulfoxides as anti-inflammatory and antidegenerative agents
US4659855A (en) * 1983-05-09 1987-04-21 Georgia Tech Research Corporation Aryl sulfonyl fluoride compounds
JPH026496A (ja) * 1988-06-27 1990-01-10 Ishihara Sangyo Kaisha Ltd 有機リン酸アミド系化合物、それらの製造方法及びそれらを含有する有害動物防除剤
US5236917A (en) * 1989-05-04 1993-08-17 Sterling Winthrop Inc. Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
NZ233521A (en) * 1989-05-04 1992-05-26 Sterling Drug Inc 2-substituted saccharin derivatives, preparation and pharmaceutical compositions thereof
AU642537B2 (en) * 1990-11-01 1993-10-21 Sanofi 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof

Also Published As

Publication number Publication date
TW225538B (enExample) 1994-06-21
FI925875L (fi) 1993-06-28
AU2829492A (en) 1993-07-01
ATE150755T1 (de) 1997-04-15
DE69218568D1 (de) 1997-04-30
MY106897A (en) 1995-08-30
MX9207542A (es) 1993-06-01
DE69218568T2 (de) 1997-11-13
EP0549073B1 (en) 1997-03-26
DK0549073T3 (da) 1997-10-06
CA2085427A1 (en) 1993-06-28
GR3023632T3 (en) 1997-08-29
IL116601A (en) 1997-04-15
HUT63630A (en) 1993-09-28
CZ371692A3 (en) 1994-04-13
RU2091377C1 (ru) 1997-09-27
IL104229A (en) 1997-02-18
NO924991L (no) 1993-06-28
JPH05271262A (ja) 1993-10-19
HU9204123D0 (en) 1993-04-28
NZ245585A (en) 1995-05-26
AU648938B2 (en) 1994-05-05
EP0549073A1 (en) 1993-06-30
FI925875A0 (fi) 1992-12-23
US5187173A (en) 1993-02-16
IL116601A0 (en) 1996-03-31
NO303639B1 (no) 1998-08-10
SK371692A3 (en) 1995-05-10
SG48310A1 (en) 1998-04-17
NO924991D0 (no) 1992-12-23
IL104229A0 (en) 1993-05-13
ES2100274T3 (es) 1997-06-16

Similar Documents

Publication Publication Date Title
GR3026222T3 (en) Novel mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
ATE283264T1 (de) Zwischenprodukte zur herstellung von metallproteinasehemmern
NZ239359A (en) Peptide-boronic acid derivatives as serine protease inhibitors
AU657166B2 (en) Novel 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
HU9203075D0 (en) 2-substituted indene-2-carboxi-alkyl derivatives being inhibitors of encefalinase and ace
DE69200286D1 (de) Verfahren zur Auswertung des Abnutzungszustandes von Erzeugnissen.
NO173884C (no) Fremgangsmaate for fremstilling av slitasje-motstandsdyktig gjenstand
YU51694A (sh) Postupak za dobijanje n-amino-1-hidroksi-alkilden-1,1-bifosfinskih kiselina
NO903419D0 (no) Fremgangsmaate for rensning av aminometylenfosfonsyrer.
DE68921565D1 (de) Verfahren zur Herstellung von Phosphoren.
EP0471756A4 (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof
ATE267180T1 (de) Phosphorderivate zur behandlung von aids
FI925946A7 (fi) Uusia 2-sakkarinyylimetyyliaryyli- ja -aryylioksiasetaatteja, jotka ovat käyttökelpoisia proteolyyttisten entsyymien inhibiittoreina, niitä sisältäviä koostumuksia ja niiden käyttö
ITMI921552A0 (it) Procedimento per la preparazione di glicerofosfolipidi
DE69027569D1 (de) Verfahren zur Herstellung von Enynderivaten
FI925875A7 (fi) Menetelmä uusien proteolyyttisten entsyymien inhibiittoreina käyttökelpoisten 2-sakkarinyylimetyyli- ja 4,5,6,7-tetrahydro-2-sakkarinyylimetyylifosfaattien, -fosfonaattien ja -fosfinaattien valmistamiseksi
DE69402201D1 (de) Phosphorhaltiges, metallurgisches silizium zur herstellung von organohalosilanen
IT1176404B (it) Procedimento per la produzione di l-amminoacidi da alfa-chetoacidi
DE59305733D1 (de) Verfahren zur Herstellung von 1,3-Difluorbenzol
AU5058393A (en) Novel 2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
FI912005A0 (fi) Menetelmä pysyvämuotoisten tuotteiden valmistamiseksi
EP0617040A3 (en) Production of alkyl phosphites.
GB2215722B (en) Process for the preparation of triaryl phosphates
NO905003D0 (no) Fremgangsmaate for fremstilling av proteaseinhibitorer frapotetsaft.
NO901422D0 (no) Fremgangsmaate for fremstilling av alfa-glucosidase-inhibitorer.

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: SANOFI